You have 9 free searches left this month | for more free features.

TIM-3

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Hepatocellular Carcinoma Trial in Beijing (Autologous RAK cells)

Recruiting
  • Hepatocellular Carcinoma
  • Autologous RAK cells
  • Beijing, Beijing, China
    Beijing Hospital Center of Biotherapy
Feb 13, 2023

Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

Active, not recruiting
  • Glioblastoma Multiforme
  • Stanford, California
  • +1 more
Nov 22, 2022

TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System

Completed
  • Lymphoma, B-Cell
    • Montpellier, France
      Uh Montpellier
    Nov 12, 2021

    Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

    Not yet recruiting
    • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
    • +2 more
    • Biopsy
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 28, 2023

    Solid Tumor, Lymphoma Trial (LB1410)

    Recruiting
    • Solid Tumor
    • Lymphoma
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Dec 27, 2022

    Advanced Solid Tumor Trial (NB002)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Jun 29, 2023

    Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Dostarlimab (TSR-042) (singly)
    • Dostarlimab (TSR-042) and TSR-022 (combination)
    • Washington, District of Columbia
    • +2 more
    Feb 22, 2022

    Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym023)

    Completed
    • Metastatic Cancer
    • +2 more
    • Grand Rapids, Michigan
    • +3 more
    Oct 11, 2021

    Pre-Eclampsia Trial (real time PCR)

    Not yet recruiting
    • Pre-Eclampsia
    • real time PCR
    • (no location specified)
    Mar 22, 2022

    Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

    Completed
    • Metastatic Cancer
    • +2 more
    • Grand Rapids, Michigan
    • +3 more
    Oct 25, 2022

    Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in

    Recruiting
    • Adult Primary Liver Cancer
    • +2 more
    • TSR-022 and TSR-042
    • Honolulu, Hawaii
      University of Hawaii
    Sep 22, 2021

    NSCLC Trial in Worldwide (AZD7789)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Atlanta, Georgia
    • +8 more
    Jan 12, 2023

    Metastatic Cancer, Solid Tumor Trial in Worldwide (Sym021, Sym022, Sym023)

    Active, not recruiting
    • Metastatic Cancer
    • Solid Tumor
    • Aurora, Colorado
    • +17 more
    Sep 8, 2022

    MDS Trial in Boston (MBG453)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Boston, Massachusetts
    • +2 more
    Mar 28, 2021

    Solid Tumor Trial in Worldwide (LY3321367, LY3300054)

    Active, not recruiting
    • Solid Tumor
    • Tucson, Arizona
    • +14 more
    Sep 2, 2021

    Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

    Recruiting
    • Neoplasms
    • Goodyear, Arizona
    • +71 more
    Dec 9, 2022

    Advanced or Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (RO7121661, RO7247669, Nivolumab)

    Recruiting
    • Advanced or Metastatic Esophageal Squamous Cell Carcinoma
    • Buenos Aires, Argentina
    • +79 more
    Aug 3, 2022

    Electrode-modiolus Distance and Cochlear Fibrosis Using Depth

    Recruiting
    • Sensorineural Hearing Loss
    • Fibrosis
    • Transimedance Matrix measurements
    • +2 more
    • Montpellier, France
      University Hospital Montpellier
    Jan 31, 2023

    Ulcerative Colitis, Crohn Disease Trial in United States (Pragmatic)

    Recruiting
    • Ulcerative Colitis
    • Crohn Disease
    • Pragmatic
    • Irvine, California
    • +20 more
    Jan 9, 2023

    Head Neck Cancer Trial (Retifanlimab, INCAGN02385, INCAGN02390)

    Recruiting
    • Head and Neck Cancer
    • Scottsdale, Arizona
    • +87 more
    Dec 12, 2022

    Galectin-9 in Rheumatoid Arthritis and Its Correlation With

    Not yet recruiting
    • Rheumatoid Arthritis
      • (no location specified)
      Jun 21, 2022

      Depressive Symptoms Trial (TIM&SARA)

      Terminated
      • Depressive Symptoms
      • TIM&SARA
      • (no location specified)
      Jun 29, 2022

      The Status of Immune Checkpoints at Gastrointestinal Cancer

      Completed
      • Gastrointestinal Cancer
      • Flow cytometric analysis
      • Istanbul, Turkey
        Istanbul Training and Reseach Hospital
      Dec 4, 2022

      Immune Checkpoints in Intraabdominal Ascites Fluid

      Completed
      • Colorectal Cancer
      • Flow-cytometric analysis
      • Istanbul, Turkey
        Ufuk Oguz Idiz
      Dec 4, 2022